Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNPAT | O15228 | 1/20 | 0.41 |
| ▸ | ACE | P12821 | 6/20 | 0.38 |
| ▸ | MME | P08473 | 4/20 | 0.36 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.36 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.36 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.36 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19051472 | 0.92 | SLC6A5 (0.39) | GNPATACEMMEPIN1SLC6A5 | |
| SCHEMBL2633324 | 0.89 | ACE (0.36) | GNPATACEPIN1SLC6A5 | |
| SCHEMBL2633410 | 0.89 | PARP1 (0.37) | GNPATACEMME | |
| SCHEMBL29071836 | 0.89 | PIN1 (0.36) | ACEPIN1SLC6A5 | |
| SCHEMBL29893883 | 0.89 | PIN1 (0.34) | ACEMMEPIN1SLC6A5NAALAD2 | |
| Carnosine SCHEMBL33769 | 0.88 | ITGB3 (0.41) | ACEPIN1SLC6A5 | |
| SCHEMBL4295456 | 0.88 | ITGB3 (0.45) | ACEPIN1SLC6A5 | |
| Carnosine SCHEMBL33768 | 0.88 | ITGB3 (0.41) | ACEPIN1SLC6A5 | |
| Carnosine SCHEMBL1161010 | 0.88 | ITGB3 (0.41) | ACEPIN1SLC6A5 | |
| SCHEMBL7780968 | 0.88 | FNTA (0.37) | ACEPIN1SLC6A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9668973-B2 | Components for producing amphoteric liposomes | MARINA BIOTECH, INC. (US) | 2017-06-06 | — | — | US | disclosed |
| US-20150118291-A1 | Amphoteric Liposome Formulation | NOVOSOM VERWALTUNGS GMBH (DE) | 2015-04-30 | — | — | US | disclosed |
| US-20140227345-A1 | COMPONENTS FOR PRODUCING AMPHOTERIC LIPOSOMES | MARINA BIOTECH, INC. (US) | 2014-08-14 | — | — | US | disclosed |
| US-20140056970-A1 | EFFICIENT METHOD FOR LOADING AMPHOTERIC LIPOSOMES WITH NUCLEIC ACID ACTIVE SUBSTANCES | MARINA BIOTECH, INC. (US) | 2014-02-27 | — | — | US | disclosed |
| US-8580297-B2 | Components for producing amphoteric liposomes | MARINA BIOTECH, INC. (US) | 2013-11-12 | — | — | US | disclosed |
| US-8367628-B2 | Amphoteric liposome formulation | PRONAI THERAPEUTICS, INC. (US) | 2013-02-05 | — | — | US | disclosed |
| US-8193246-B2 | Lipids and lipid assemblies comprising transfection enhancer elements | MARINA BIOTECH, INC. (US) | 2012-06-05 | — | — | US | disclosed |
| US-20120100205-A1 | COMPONENTS FOR PRODUCING AMPHOTERIC LIPOSOMES | MARINA BIOTECH, INC. | 2012-04-26 | — | — | US | disclosed |
| US-20120021042-A1 | Efficient Method For Loading Amphoteric Liposomes With Nucleic Acid Active Substances | MARINA BIOTECH, INC. | 2012-01-26 | — | — | US | disclosed |
| US-20080306153-A1 | Lipids and lipid assemblies comprising transfection enhancer elements | CEQUENT PHARMACEUTICALS, INC. | 2008-12-11 | — | — | US | disclosed |
| US-20080145413-A1 | Lipids and lipid assemblies comprising transfection enhancer elements | MARINA BIOTECH, INC. | 2008-06-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080145413-A1 | Lipids and lipid assemblies comprising transfection enhancer elements | HNRNPH3, SREBF2, PHOSPHO1 | GNPAT 2741/4885ACE 4346/4885MME 2411/4885 |
| US-20080306153-A1 | Lipids and lipid assemblies comprising transfection enhancer elements | SREBF1, SREBF2, ELOVL1 | GNPAT 2586/4885ACE 4246/4885MME 2489/4885 |
| US-20150118291-A1 | Amphoteric Liposome Formulation | ANXA5, ANXA11, CLPTM1L | GNPAT 275/4885ACE 4870/4885MME 3721/4885 |
| US-20140227345-A1 | COMPONENTS FOR PRODUCING AMPHOTERIC LIPOSOMES | PHOSPHO1, SGMS1, CHMP4B | GNPAT 513/4885ACE 4141/4885MME 1442/4885 |
| US-20120021042-A1 | Efficient Method For Loading Amphoteric Liposomes With Nucleic Acid Active Substances | LIPA, ANXA7, ANXA1 | GNPAT 486/4885ACE 3710/4885MME 2086/4885 |
| US-20120100205-A1 | COMPONENTS FOR PRODUCING AMPHOTERIC LIPOSOMES | PHOSPHO1, SGMS1, CHMP4B | GNPAT 513/4885ACE 4141/4885MME 1442/4885 |
| US-20140056970-A1 | EFFICIENT METHOD FOR LOADING AMPHOTERIC LIPOSOMES WITH NUCLEIC ACID ACTIVE SUBSTANCES | LIPA, ANXA7, ANXA6 | GNPAT 515/4885ACE 3762/4885MME 2128/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.